MBC Support Group for Black Women – Insights in Genetic Testing
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions. https://www.youtube.com/watch?v=zw3vXC8v8vI
Report Back from SGO: What’s the Latest in Cervical Cancer?
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the […]
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Are you curious about what’s new in ovarian cancer research or unsure what the findings mean? Join Dr. Elena Pereira, a gynecologic oncologist at Lenox Hill Hospital, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Pereira will discuss what the research presented at […]
Report Back from SGO: What’s New in Uterine Cancer?
Dr. Ebony Hoskins, gynecologic oncologist at MedStar Washington Hospital Center, provides a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Hoskins breaks down the research presented at the conference, discusses new developments, and addresses the most pressing questions. Key Takeaways from Webinar Viewers: Clinical trials matter. It is […]
Why Black Data Matters in Clinical Trial Research
We are excited to be joined by Ricki Fairley, a CEO and co-founder of TOUCH, Black Breast Cancer Alliance, who is also a triple-negative (TNBC) survivor. Ricki discusses the importance of the Black Data Matters (BDM) initiative established in June 2020. The main aim of this initiative is to bring attention to and focus on […]
What’s New with PARP Inhibitors and Ovarian Cancer?
PARP inhibitors have revolutionized ovarian cancer treatment, but recent updates to the FDA-approved indications have caused confusion and raised questions for patients. So what do these changes mean? Dr. Thomas Herzog, Deputy Director of the University of Cincinnati Cancer Center, discusses the current landscape of PARP inhibitors for ovarian cancer and what it means for […]
Part II: DCIS Research: De-escalating the Fear of Recurrence
Ductal carcinoma in situ (DCIS) can be treated with surgery, or with Active Monitoring for low-risk DCIS. Chemotherapy is not needed, although sometimes radiation or hormone therapy are suggested. Most DCIS never develops into an invasive cancer. In part 2 of the DCIS webinar series, we discuss where research is taking us. For those who […]
Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight on the Latest in MBC
We are thrilled to have Dr. Timothy Pluard, director of the Saint Luke’s Koontz Center for Advanced Breast Cancer, explain the recent research released at the annual San Antonio Breast Cancer Symposium (SABCS), 2023. Watch this webinar to gain a better understanding of what all the new data means to you and hear the answers […]
Why are Breast Cancers More Aggressive in Black Women?
There are striking disparities in survival rates between Black and white breast cancer patients. Our guest speakers, Christine Ambrosone, PhD, and Song Yao, MD, PhD, have led a team that has done extensive research to understand the causes of why certain cancers are more aggressive in Black women. They have developed a hypothesis that the […]